Overview

Efficacy and Safety of Danzhen

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose is to evaluate the effectiveness and safety profile of Danzhen for the prophylaxis of migraine in a "real-world" setting.
Phase:
Phase 1
Details
Lead Sponsor:
Xijing Hospital
Collaborator:
Ecion Pharmaceutical CO..LTD
Treatments:
Topiramate